Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-39,627
Closed -$10.6M 29
2026
Q1
$10.6M Sell
39,627
-3,259
-8% -$902K 3.54% 14
2025
Q4
$11.8M Buy
42,886
+4,046
+10% +$1.13M 3.65% 16
2025
Q3
$11.2M Sell
38,840
-1,850
-5% -$547K 3.55% 17
2025
Q2
$13.5M Sell
40,690
-12,852
-24% -$4.14M 3.74% 17
2025
Q1
$17.6M Sell
53,542
-914
-2% -$275K 4.35% 10
2024
Q4
$15M Buy
54,456
+5,021
+10% +$1.6M 3.75% 16
2024
Q3
$17.1M Buy
49,435
+3,394
+7% +$1.17M 4.06% 14
2024
Q2
$15.2M Buy
46,041
+36
+0.1% +$12.4K 4.1% 15
2024
Q1
$16.7M Sell
46,005
-3,820
-8% -$1.26M 4.52% 10
2023
Q4
$14.9M Sell
49,825
-587
-1% -$172K 4.25% 13
2023
Q3
$14.4M Buy
50,412
+2,116
+4% +$603K 4.42% 12
2023
Q2
$13.6M Buy
48,296
+884
+2% +$230K 4.18% 11
2023
Q1
$12.1M Buy
47,412
+1,196
+3% +$348K 4.03% 14
2022
Q4
$15.3M Buy
46,216
+56
+0.1% +$17.7K 5.13% 5
2022
Q3
$12.8M Sell
46,160
-21,275
-32% -$5.99M 4.63% 8
2022
Q2
$17.8M Buy
67,435
+6,515
+11% +$1.68M 6.06% 2
2022
Q1
$14.6M Sell
60,920
-338
-0.6% -$79.1K 4.36% 11
2021
Q4
$14.1M Buy
+61,258
New +$13M 4.08% 12
2020
Q1
Sell
-40,000
Closed -$8.32M 36
2019
Q4
$8.32M Buy
40,000
+282
+0.7% +$51.7K 4.22% 8
2019
Q3
$5.9M Buy
39,718
+3,271
+9% +$532K 3.4% 14
2019
Q2
$5.75M Buy
+36,447
New +$5.71M 3.19% 16

Other funds holding CI

Nepsis Inc's CI Position: Q2 2026 in Review

Nepsis Inc sold out of Cigna (CI) in Q2 2026, closing a stake of 39,627 shares — an estimated $10.6M sold.

Nepsis Inc first reported a position in CI in Q2 2019 and held it in 21 quarters. The position peaked at $17.8M in Q2 2022. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • Nepsis Inc reported no remaining Cigna position as of Q2 2026 after selling out during the quarter.
  • Nepsis Inc sold 39,627 Cigna shares in Q2 2026, an estimated $10.6M.
  • Nepsis Inc first reported a position in Cigna in Q2 2019 and held it in 21 quarters.
  • Nepsis Inc's Cigna position peaked at $17.8M in Q2 2022.
  • 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Nepsis Inc's 13F filing for Q2 2026, filed 14 Jul 2026.